Company news

Neovasc Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences

January 22, 2019

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

January 14, 2019

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

January 3, 2019

Neovasc Receives ISO 13485: 2016 Certification

December 21, 2018

Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC

December 11, 2018

JACC: Cardiovascular Interventions Publishes Peer Reviewed Article on Neovasc Reducer(TM) Patient Case

November 20, 2018

Neovasc Announces Third Quarter 2018 Financial Results

November 14, 2018

Neovasc Announces Third Quarter 2018 Financial Results Conference Call and Webcast

November 7, 2018

Neovasc Announces Successful Tiara(TM) "Live Case" at the 32nd Annual EACTS 2018 Meeting

October 22, 2018

Neovasc Announces Publication of a Peer-Reviewed Article on Tiara(TM) Cases in Circulation: Cardiovascular Interventions

October 16, 2018

Neovasc Reducer(TM) Granted Breakthrough Device Designation from FDA

October 10, 2018

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule

October 9, 2018

Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer(TM)

October 3, 2018

Neovasc's Tiara and Reducer to be Featured at TCT 2018 Conference

September 20, 2018

Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany

September 19, 2018

Neovasc Announces Effective Date of Share Consolidation

September 18, 2018

Neovasc Announces Amendments to Outstanding Convertible Notes, including 1-Year Extension of Note Maturity Date

September 12, 2018

Neovasc Announces Second Quarter 2018 Financial Results

August 8, 2018

Neovasc Announces Updated Presentation Time at the 38th Annual Canaccord Genuity Growth Conference

August 8, 2018

Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology

August 6, 2018

Neovasc to Present at the 38th Annual Canaccord Genuity Growth Conference

August 6, 2018

Neovasc Announces Collaboration and Licensing Agreement with Penn Medicine and the Gorman Cardiovascular Research Group

August 3, 2018

Neovasc Announces Second Quarter 2018 Financial Results Conference Call and Webcast

August 2, 2018

Nasdaq Schedules Hearing to Consider Neovasc's Appeal of Delisting Determination

July 16, 2018

Neovasc Announces Filing of "Administrative" Prospectus Supplement Relating to Expiry of Prior Shelf Prospectus / Registration Statement

July 16, 2018

Neovasc Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing

July 9, 2018

Tiara and Reducer Featured at CSI Frankfurt 2018

July 2, 2018

Neovasc Announces Filing of Shelf Prospectus and Form F-10 Registration Statement

July 2, 2018

Tiara(TM) Featured in Live Case at 11th Annual TVT 2018

June 21, 2018

Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient

June 20, 2018

Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update

June 11, 2018

Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders

June 4, 2018

Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer

May 25, 2018

Neovasc's Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock Split at the Upcoming Annual General and Special Meeting of Shareholders

May 15, 2018

Neovasc Announces Results for the First Quarter 2018

May 10, 2018

Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

May 10, 2018

Neovasc Provides a General Update, Announces Filing of Annual Report on Form 20-F and Sets First Quarter 2018 Financial Results Conference Call and Webcast

April 30, 2018

Neovasc Announces Receipt of US$7.1 Million from Exercise of Series C Warrants

April 11, 2018

Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017

March 28, 2018

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

March 23, 2018

Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast

March 21, 2018

← Newer news releases

Decks

The 5 newest of 13 decks. Every deck is listed under its year.